Lp-PLA ₂ (Lipoprotein-Associated Phospholipase A ₂ ) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits

Abstract

Background: Elevated plasma Lp-PLA 2 (lipoprotein-associated phospholipase A 2 ) activity is closely associated with an increased risk of cardiovascular events. However, whether and how Lp-PLA 2 is directly involved in the pathogenesis of atherosclerosis is still unclear. To examine the hypothesis that Lp-PLA 2 could be a potential preventative target of atherosclerosis, we generated Lp-PLA 2 knockout rabbits and investigated the pathophysiological functions of Lp-PLA 2 . Methods: Lp-PLA 2 KO rabbits were generated using CRISPR/Cas9 system to assess the role of Lp-PLA 2 in plasma lipids regulation and identify its underlying molecular mechanisms. Homozygous knockout rabbits along with wild-type rabbits were fed a cholesterol-rich diet for up to 14 weeks and their atherosclerotic lesions were compared. Moreover, the effects of Lp-PLA 2 deficiency on the key cellular behaviors in atherosclerosis were assessed in vitro. Results: When rabbits were fed a standard diet, Lp-PLA 2 deficiency led to a significant reduction in plasma lipids. The decreased protein levels of SREBP2 (sterol regulatory element-binding protein 2) and HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) in livers of homozygous knockout rabbits indicated that the cholesterol biosynthetic pathway was impaired with Lp-PLA 2 deficiency. In vitro experiments further demonstrated that intracellular Lp-PLA 2 efficiently enhanced SREBP2-related cholesterol biosynthesis signaling independently of insulin-induced genes ( INSIG s). When fed a cholesterol-rich diet, homozygous knockout rabbits exhibited consistently lower level of hypercholesterolemia, and their aortic atherosclerosis lesions were significantly reduced by 60.2% compared with those of wild-type rabbits. The lesions of homozygous knockout rabbits were characterized by reduced macrophages and the expression of inflammatory cytokines. Macrophages of homozygous knockout rabbits were insensitive to M1 polarization and showed reduced DiI-labeled lipoprotein uptake capacity compared with wild-type macrophages. Lp-PLA 2 deficiency also inhibited the adhesion between monocytes and endothelial cells. Conclusions: These results demonstrate that Lp-PLA 2 plays a causal role in regulating blood lipid homeostasis and Lp-PLA 2 deficiency protects against dietary cholesterol-induced atherosclerosis in rabbits. Lp-PLA 2 could be a potential target for the prevention of atherosclerosis.

Synergistic Role of NK Cells and Monocytes in Promoting Atherogenesis in Severe COVID-19 Patients

“…Within vascular intimal tissue, hydrolysis of Ox-LDL into oxidized fatty acids contribute to endothelial dysfunction, inflammation, and foam cell formation which may alter vascular architecture 39 . Progressive atherogenesis and vascular remodeling, reflected by persistent elevations in plasma TIMP-1 and TIMP-2 despite recovery 40 is likely to contribute to the increased thromboembolic events documented following acute severe COVID-19 which has drawn significant scientific interest 41 .…”

Genome-edited rabbits: Unleashing the potential of a promising experimental animal model across diverse diseases

“…ApoE and LDL receptor ( LDLR ) knockout rabbit models created using CRISPR/Cas9 technology developed severe hyperlipidemia when exposed to a cholesterol-rich diet, showing importance for studying human hyperlipidemia and familial hypercholesterolemia ( Yang et al, 2014 ; Yuan et al, 2019 ). Most recently, Chen et al ( 2023 ) established a rabbit model deficient in the CVD risk factor lipoprotein-associated phospholipase A 2 ( Lp-PLA 2 ) and demonstrated that Lp-PLA 2 regulated blood lipid homeostasis, protecting against dietary cholesterol-induced atherosclerosis ( Chen et al, 2023 ). Overall, aided by genome editing, rabbits are expected to greatly promote investigations of CVD-related spontaneous hyperlipidemia and atherosclerosis.…”